[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fQHEMKpYlPpNZXXW3pGCIyBp7VKMFN-9SMZMhZZ893Xw":3},{"success":4,"breach":5},true,{"_id":6,"name":7,"title":8,"slug":9,"domain":10,"company":11,"breachDate":15,"addedDate":16,"modifiedDate":16,"pwnCount":17,"totalRecords":17,"dataClasses":18,"description":20,"source":21,"isVerified":4,"isSpamList":22,"isSensitive":4,"severity":23,"processingStatus":24,"logoUrl":25,"contentUpdatedAt":16,"hasEnglishDescription":4},"6a66b8ce326c910def7d068a","WestPharmaceuticalServices2026","West Pharmaceutical Services 2026 Data Breach","west-pharmaceutical-services-2026","westpharma.com",{"name":12,"sector":13,"country":14,"website":10},"West Pharmaceutical Services, Inc.","Healthcare","United States","2026-05-04T00:00:00.000Z","2026-07-27T01:47:58.689Z",0,[19],"Unspecified exfiltrated data","\u003Cp>\u003Cstrong>The West Pharmaceutical Services 2026 data breach\u003C\u002Fstrong> was a material cyberattack in which an unauthorized party exfiltrated certain data, encrypted some systems, and temporarily disrupted the pharmaceutical packaging and injectable-delivery manufacturer's global operations. The company detected the intrusion on May 4, 2026, determined on May 7 that it was material, and reported it to the U.S. Securities and Exchange Commission on May 11.\u003C\u002Fp>\n\u003Cp>Although West directly confirmed data theft, it did not disclose the type of content exfiltrated, the people or organizations affected, or a unique record count. LeakData therefore uses only the class “unspecified exfiltrated data” and does not infer employee, customer, patient, medical, financial, or identity information. pwnCount and totalRecords remain zero as unknown.\u003C\u002Fp>\n\u003Ch2>How Was the Incident Confirmed?\u003C\u002Fh2>\n\u003Cp>Item 1.05 in West Pharmaceutical Services' Form 8-K explicitly says the company experienced a material cybersecurity attack in which certain data was exfiltrated and certain systems were encrypted. This is not a threat-actor allegation; it is the public company's formal disclosure to a federal regulator. The filing dates initial detection to May 4 and the materiality determination to May 7.\u003C\u002Fp>\n\u003Cp>BleepingComputer independently reported the SEC disclosure, global operational disruption, and response details from a company spokesperson on May 13. West's second-quarter Form 10-Q, filed July 23, again described the May attack and said the incident had been contained and operations fully recovered. Together, the three sources adequately confirm the theft, encryption, initial impact, and final operational status.\u003C\u002Fp>\n\u003Ch2>How Did the Attack and Response Unfold?\u003C\u002Fh2>\n\u003Cp>After identifying the network intrusion on May 4, the company activated its incident-response protocols. Affected portions of on-premises infrastructure were proactively shut down and isolated, access to enterprise systems was restricted, law enforcement was notified, and outside cyber-forensic specialists were engaged. West also retained Palo Alto Networks Unit 42 to support investigation, containment, and recovery alongside other experts and legal counsel.\u003C\u002Fp>\n\u003Cp>The SEC filing says the attacker removed certain data from the network and encrypted some systems. Those two confirmed facts distinguish this event from a mere outage or unsuccessful access attempt. West did not disclose the initial-access method, malware used, the attacker's dwell time, or whether a ransom demand was made, so those details are not added to the record as assumptions.\u003C\u002Fp>\n\u003Ch2>What Data Was Affected?\u003C\u002Fh2>\n\u003Cp>The narrowest accurate description in the official documents is “certain data.” The company did not publicly say whether the dataset consisted of files, email, commercial documents, personal information, or another type of content. It said it had taken steps intended to mitigate the risk that the exfiltrated data would be disseminated, but did not identify the measures or say whether the data had been published.\u003C\u002Fp>\n\u003Cp>West manufactures injectable-drug packaging, vial and syringe components, containment systems, and drug-delivery devices; that business activity alone is not evidence that patient or health data was breached. Employee headcount, customer base, revenue, facility count, and manufacturing volume are not breach totals. LeakData does not add unconfirmed categories to dataClasses or derive a person count from company size.\u003C\u002Fp>\n\u003Ch2>How Much Were Operations Affected?\u003C\u002Fh2>\n\u003Cp>The incident and the company's precautionary shutdown temporarily disrupted business operations worldwide. In the May 11 statement, core enterprise systems had been restored and critical shipping, receiving, and manufacturing processes had restarted at some sites, while restoration continued elsewhere. West said it used business-continuity plans and worked with customers to mitigate risk and minimize delays.\u003C\u002Fp>\n\u003Cp>The Form 10-Q covering the period through June 30 and filed July 23 states that the incident was contained and operations had fully recovered. It grouped professional fees associated with the May incident together with various legal matters, so an exact incident-only cost cannot be calculated from that expense line. LeakData records the confirmed operational recovery but does not invent an undisclosed financial-loss amount.\u003C\u002Fp>\n\u003Ch2>Is the Ransomware Group or Threat Actor Known?\u003C\u002Fh2>\n\u003Cp>Exfiltration followed by system encryption resembles the double-extortion pattern used in ransomware operations, and some reporting described the event as ransomware. West's SEC language, however, calls it a “material cybersecurity attack” and does not confirm an actor name, ransomware family, or payment demand. BleepingComputer said no ransomware group had claimed responsibility when its report was published.\u003C\u002Fp>\n\u003Cp>The record therefore includes the verified technical behavior—data exfiltration and system encryption—without attributing it to a named ransomware brand or actor. Any later leak-site listing is not treated as a person count or a data class unless the company or independent technical evidence validates it. This separates a genuine, company-confirmed breach from an attacker's promotional claims.\u003C\u002Fp>\n\u003Ch2>How Should This LeakData Record Be Read?\u003C\u002Fh2>\n\u003Cp>The breachDate is May 4, 2026, when the company first detected the network intrusion; the May 7 materiality decision and May 11 SEC publication are disclosure milestones. The confirmed event is the removal of unspecified data from West's network, encryption of some systems, and temporary disruption of global operations. By July, the event was contained and operations had fully recovered.\u003C\u002Fp>\n\u003Cp>Zero values for pwnCount and totalRecords do not mean that no data was stolen; West confirmed exfiltration but did not provide a numeric scope. Readers should not use this record as proof that a particular employee, customer, or patient data type was exposed. If West later publishes notification totals or specific data categories, the record can be updated after those facts are verified against original sources.\u003C\u002Fp>","Material cyberattack with data exfiltration and system encryption",false,"Low","completed","\u002Fuploads\u002Flogo\u002Fwestpharma_com.jpg"]